Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...

Researchers have developed light-transmitting hydrogel fibers that are just hundreds of micrometers in diameter. With further ...

Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

There is a constant war going on in your body. Working against you are viruses and cancer cells growing uncontrollably, threatening your tissues and organs. Fighting on your side are immune cells such ...

The Blackstone president and his wife are funding a new Penn institute that uses AI and biomarkers to intercept hereditary cancers at their earliest stages.

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.